DocGo (DCGO) - 2025 Q2 - Quarterly Report
2025-08-08 04:19
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2025 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-39618 DocGo Inc. (Exact Name of Registrant as Specified in Its Charter) | Delaware | 85-2515483 | | --- | --- ...
Valley National Bancorp Series C Pfd(VLYPN) - 2025 Q2 - Quarterly Report
2025-08-08 04:19
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q (Mark One) ☒ Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Quarterly Period Ended June 30, 2025 OR ☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to Commission File Number 1-11277 Valley National Bancorp (Exact name of registrant as specified in its charter) New Jersey 22-2477875 (State or other jurisdicti ...
VALLEY NATIONAL(VLYPP) - 2025 Q2 - Quarterly Report
2025-08-08 04:19
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q (Mark One) ☒ Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Quarterly Period Ended June 30, 2025 OR ☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to Commission File Number 1-11277 Valley National Bancorp (Exact name of registrant as specified in its charter) New Jersey 22-2477875 (State or other jurisdicti ...
Valley National Bancorp(VLY) - 2025 Q2 - Quarterly Report
2025-08-08 04:19
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q (Mark One) ☒ Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Quarterly Period Ended June 30, 2025 OR ☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to Commission File Number 1-11277 Valley National Bancorp (Exact name of registrant as specified in its charter) New Jersey 22-2477875 (State or other jurisdicti ...
Rocket Lab USA(RKLB) - 2025 Q2 - Quarterly Results
2025-08-08 04:19
Exhibit 99.1 Rocket Lab Announces Second Quarter 2025 Financial Results, Posts Record Quarterly Revenue of $144m, Representing 36% Year-on-Year Growth, And Gross Margin Expansion Exceeding Expectations Long Beach, California. August 7, 2025 – Rocket Lab Corporation (Nasdaq: RKLB) ("Rocket Lab", "the Company", "we," "us," or "our"), a global leader in launch services and space systems, today shared the financial results for fiscal second quarter ended June 30, 2025. Rocket Lab founder and CEO, Sir Peter Beck ...
Sight Sciences(SGHT) - 2025 Q2 - Quarterly Report
2025-08-08 04:19
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from __________ to ____________ Commission File Number: 001-40587 SIGHT SCIENCES, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 80-0625749 (State or other jurisdict ...
AMN Healthcare Services(AMN) - 2025 Q2 - Quarterly Results
2025-08-08 04:19
| | Q2 2025 | | % | Change Q2 | YTD | June | 30, | % | Change | YTD | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | | | | | 2024 | | 2025 | | June | 30, | 2024 | | Revenue | | $658.2 | | (11%) | | $1,347.7 | | | (14%) | | | Gross profit | | $196.4 | | (15%) | | $394.5 | | | (19%) | | | Net loss | | ($116.2) | | nm | | ($117.3) | | | nm | | | Diluted loss per share | | ($3.02) | | nm | | ($3.06) | | | nm | | | Adjusted diluted EPS* | | $0.30 | | (69%) | | $0.75 | | | (62%) | | | Adjus ...
Trevi Therapeutics(TRVI) - 2025 Q2 - Quarterly Report
2025-08-08 04:19
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) For the quarterly period ended June 30, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-38886 TREVI THERAPEUTICS, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 45-0834299 ( State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.) 195 Church St ...
Global Net Lease(GNL) - 2025 Q2 - Quarterly Report
2025-08-08 04:19
(Exact name of registrant as specified in its charter) Maryland 45-2771978 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | (Mark One) | | | --- | --- | | ☒ | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | | | For the quarterly period ended June 30, 2025 | | | OR | | ☐ | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | | | For the transition period from _________ to __________ | | | Commis ...
Carriage Services(CSV) - 2025 Q2 - Quarterly Report
2025-08-08 04:19
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ___________ to ____________ Commission File Number: 1-11961 CARRIAGE SERVICES, INC. (Exact name of registrant as specified in its charter) Delaware 76-0423828 ( ...